Amgen Inc. (AMGN) is listed on NasdaqGS in the Healthcare sector Β· Drug Manufacturers - General industry. The current price is 443.63, up 0.18% from the previous close. Market cap is approximately $236.9B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
AMGN's 26.67x P/E is in premium territory. Justifiable while growth accelerates, but this is also the band that reacts first to guidance cuts or macro shocks.
ROE of 91.47% signals strong capital efficiency. High-ROE firms typically have more headroom for dividends and buybacks.
Amgen Inc.'s elevated D/E of 490.28 either reflects an aggressive growth-via-debt strategy or balance sheet stress. Operating cash flow trend is the cleanest tell.
AMGN's 9.50% revenue growth is modest. In this band, buybacks and dividends often drive most of the EPS and total return.
Dividend yield of 2.34% is around the market average. Suitable for a balanced income + modest capital appreciation posture.
Demographic-driven structural demand growth is a long-running tailwind for healthcare.
Amgen Inc. is near its 52-week high (447.03), in the top 2% of the range. Prices close to new highs invite two readings β little overhead supply, or stretched expectations β and volume is the usual tiebreaker.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app
The stock moved within a 1.77% high-to-low band on the day, closing 0.18%. That falls within a typical intraday range.
Amgen Inc. (AMGN) is listed on NasdaqGS, with recent volume of 486,335 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.